Creative Biogene, a biotechnology company specializing in RNA delivery technologies, announced the launch of its custom RNA services, designed to support the growing field of RNA research and its applications in drug development and therapeutics. The services include the synthesis and customization of mRNA, self-amplifying RNA (saRNA), circular RNA (circRNA), and RNA interference (RNAi) molecules, catering to academic laboratories and pharmaceutical companies alike.
In today's rapidly evolving RNA research landscape, RNA has transformed from a research subject into a key element in drug development. With the emergence of technologies such as mRNA vaccines, circRNA, and saRNA, the demand for customized RNA solutions has increased. Creative Biogene's new service aims to bridge basic research and practical applications by providing tailored solutions, including sophisticated modifications to enhance stability and efficacy. The company offers production scales from micrograms to grams, ensuring flexibility for both basic research and large-scale therapeutics.
The custom RNA service also provides dedicated support for miRNA and circRNA research, including precise sequence design and expression profiling of miRNAs, and efficient synthesis and functional analysis of circRNAs. This launch marks the establishment of Creative Biogene's one-stop Contract Development and Manufacturing Organization (CDMO) platform, integrating all stages of RNA drug development from sequence design and in vitro transcription to GMP-grade manufacturing and validation. The CDMO services encompass comprehensive analytical services for assessing RNA integrity and ensuring compliance with stringent regulatory requirements. Additionally, the introduction of lipid nanoparticle (LNP) encapsulation technology enables efficient multi-component co-encapsulation for diverse therapeutic needs.
Creative Biogene emphasizes rigorous quality control, ensuring batch-to-batch consistency and purity to meet industry standards. According to Marcia Brady, marketing director of Creative Biogene, the company is committed to becoming a leader in the RNA services market, with a team of scientists experienced in molecular biology, RNA chemistry, and drug development. The goal is to provide researchers with tools to translate experimental discoveries into practical applications, based on scientific principles and operational excellence.
For more information about Creative Biogene's custom RNA services, visit their official website at https://www.creative-biogene.com. The company currently has scale-up expertise and unique mRNA, oligonucleotide, and plasmid production capabilities for companies focused on therapeutic, vaccine, diagnostic, and biopharmaceutical breakthroughs.
